- Home
- EOD vs NPCE Comparison
EOD vs NPCE Comparison
Compare EOD & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOD
- NPCE
- Stock Information
- Founded
- EOD 2007
- NPCE 1997
- Country
- EOD United States
- NPCE United States
- Employees
- EOD N/A
- NPCE N/A
- Industry
- EOD Investment Managers
- NPCE Medical Specialities
- Sector
- EOD Finance
- NPCE Health Care
- Exchange
- EOD Nasdaq
- NPCE Nasdaq
- Market Cap
- EOD 245.0M
- NPCE 292.9M
- IPO Year
- EOD N/A
- NPCE 2021
- Fundamental
- Price
- EOD $5.62
- NPCE $9.89
- Analyst Decision
- EOD
- NPCE Strong Buy
- Analyst Count
- EOD 0
- NPCE 6
- Target Price
- EOD N/A
- NPCE $16.67
- AVG Volume (30 Days)
- EOD 118.1K
- NPCE 178.3K
- Earning Date
- EOD 01-01-0001
- NPCE 11-11-2025
- Dividend Yield
- EOD 9.28%
- NPCE N/A
- EPS Growth
- EOD N/A
- NPCE N/A
- EPS
- EOD N/A
- NPCE N/A
- Revenue
- EOD N/A
- NPCE $88,570,000.00
- Revenue This Year
- EOD N/A
- NPCE $22.13
- Revenue Next Year
- EOD N/A
- NPCE $6.07
- P/E Ratio
- EOD N/A
- NPCE N/A
- Revenue Growth
- EOD N/A
- NPCE 23.32
- 52 Week Low
- EOD $3.73
- NPCE $5.45
- 52 Week High
- EOD $4.71
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- EOD 43.87
- NPCE 59.36
- Support Level
- EOD $5.65
- NPCE $9.65
- Resistance Level
- EOD $5.71
- NPCE $10.12
- Average True Range (ATR)
- EOD 0.05
- NPCE 0.39
- MACD
- EOD -0.02
- NPCE 0.07
- Stochastic Oscillator
- EOD 5.26
- NPCE 75.09
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.